Deep Track Capital, LP, (together with its affiliates, "Deep Track" or "we"), one of the largest shareholders of Dynavax Technologies Corporation (NASDAQ: DVAX) ("Dynavax", "DVAX" or the "Company"), ...

GREENWICH, Conn., June 09, 2025--Deep Track Capital, LP, (together with its affiliates, "Deep Track" or "we"), one of the largest shareholders of Dynavax Technologies Corporation (NASDAQ: DVAX) ...

Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom ...

The participants in the proxy solicitation are Deep Track, Deep Track Biotechnology Master Fund, Ltd. (the “Record Stockholder”), David Kroin (all of the foregoing persons, collectively, the ...

Chief operating officer Michael Mullette – a pharma industry veteran with experience at Moderna and Sanofi – has been named interim CEO, ...

Only a few weeks later, Lykos’ CEO, Amy Emerson, decided to step down, with Michael Mullette becoming interim CEO to lead further discussions with the FDA over the next steps for midomafetamine.

The Church Corner runs Friday or Saturday. To list or change church services in this directory call Janice at 447-4083 or fax changes to 447-4052.

Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders of Dynavax Technologies Corporation (NASDAQ: DVAX) (“Dynavax”, “DVAX” or the “Company”), ...

Deep Track’s nominees, Brett Erkman, Jeffrey Farrow, Michael Mullette, and Donald Santel, are positioned as independent voices aimed at refocusing the company’s strategic direction and improving ...